LYCIA THERAPEUTICS Trademark

Trademark Overview


On Monday, April 26, 2021, a trademark application was filed for LYCIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LYCIA THERAPEUTICS trademark a serial number of 90672001. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, August 6, 2024. This trademark is owned by Lycia Therapeutics, Inc.. The LYCIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therape...
lycia therapeutics

General Information


Serial Number90672001
Word MarkLYCIA THERAPEUTICS
Filing DateMonday, April 26, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLycia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameLycia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Thursday, April 29, 2021NEW APPLICATION ENTERED
Saturday, July 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 21, 2021ASSIGNED TO EXAMINER
Wednesday, December 22, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 22, 2021NON-FINAL ACTION WRITTEN
Thursday, June 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 24, 2023SOU EXTENSION 1 FILED
Thursday, January 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023SOU EXTENSION 2 FILED
Thursday, August 17, 2023SOU EXTENSION 2 GRANTED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 2, 2024SOU EXTENSION 3 FILED
Friday, February 2, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 6, 2024SOU EXTENSION 4 FILED
Tuesday, February 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED